Notice: This company has been marked as potentially delisted and may not be actively trading. Oaktree Acquisition (OAC) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrends OAC vs. TDOC, SBC, AUNA, AIRS, LFMD, SHLT, CCM, TOI, HIMS, and XENEShould you be buying Oaktree Acquisition stock or one of its competitors? The main competitors of Oaktree Acquisition include Teladoc Health (TDOC), SBC Medical Group (SBC), Auna (AUNA), AirSculpt Technologies (AIRS), LifeMD (LFMD), SHL Telemedicine (SHLT), Concord Medical Services (CCM), Oncology Institute (TOI), Hims & Hers Health (HIMS), and Xenon Pharmaceuticals (XENE). Oaktree Acquisition vs. Teladoc Health SBC Medical Group Auna AirSculpt Technologies LifeMD SHL Telemedicine Concord Medical Services Oncology Institute Hims & Hers Health Xenon Pharmaceuticals Teladoc Health (NYSE:TDOC) and Oaktree Acquisition (NYSE:OAC) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, risk, analyst recommendations, earnings, community ranking, dividends and institutional ownership. Do institutionals and insiders believe in TDOC or OAC? 76.8% of Teladoc Health shares are owned by institutional investors. Comparatively, 47.6% of Oaktree Acquisition shares are owned by institutional investors. 1.0% of Teladoc Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is TDOC or OAC more profitable? Oaktree Acquisition has a net margin of 0.00% compared to Teladoc Health's net margin of -37.91%. Oaktree Acquisition's return on equity of 0.00% beat Teladoc Health's return on equity.Company Net Margins Return on Equity Return on Assets Teladoc Health-37.91% -10.06% -4.86% Oaktree Acquisition N/A N/A N/A Does the MarketBeat Community believe in TDOC or OAC? Teladoc Health received 675 more outperform votes than Oaktree Acquisition when rated by MarketBeat users. However, 100.00% of users gave Oaktree Acquisition an outperform vote while only 62.95% of users gave Teladoc Health an outperform vote. CompanyUnderperformOutperformTeladoc HealthOutperform Votes67862.95% Underperform Votes39937.05% Oaktree AcquisitionOutperform Votes3100.00% Underperform VotesNo Votes Do analysts recommend TDOC or OAC? Teladoc Health presently has a consensus target price of $12.24, indicating a potential upside of 11.04%. Given Teladoc Health's stronger consensus rating and higher possible upside, research analysts plainly believe Teladoc Health is more favorable than Oaktree Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Teladoc Health 0 Sell rating(s) 14 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.33Oaktree Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has better valuation & earnings, TDOC or OAC? Oaktree Acquisition has lower revenue, but higher earnings than Teladoc Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTeladoc Health$2.60B0.73-$220.37M-$5.77-1.91Oaktree AcquisitionN/AN/A$1.15MN/AN/A Which has more risk & volatility, TDOC or OAC? Teladoc Health has a beta of 0.97, suggesting that its stock price is 3% less volatile than the S&P 500. Comparatively, Oaktree Acquisition has a beta of 0.17, suggesting that its stock price is 83% less volatile than the S&P 500. Does the media prefer TDOC or OAC? In the previous week, Teladoc Health had 9 more articles in the media than Oaktree Acquisition. MarketBeat recorded 9 mentions for Teladoc Health and 0 mentions for Oaktree Acquisition. Teladoc Health's average media sentiment score of 1.06 beat Oaktree Acquisition's score of 0.00 indicating that Teladoc Health is being referred to more favorably in the media. Company Overall Sentiment Teladoc Health Positive Oaktree Acquisition Neutral SummaryTeladoc Health beats Oaktree Acquisition on 10 of the 15 factors compared between the two stocks. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Oaktree Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for OAC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OAC vs. The Competition Export to ExcelMetricOaktree AcquisitionOffices & Clinics Of Medical Doctors IndustryMedical SectorNYSE ExchangeMarket Cap$810.28M$1.21B$5.18B$20.24BDividend YieldN/AN/A5.36%3.44%P/E RatioN/A12.88129.5343.21Price / SalesN/A1.751,292.6417.82Price / Cash377.4545.9941.9222.41Price / Book161.059.674.875.55Net Income$1.15M-$52.07M$118.66M$983.78M Oaktree Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OACOaktree AcquisitionN/A$32.21+4.4%N/A+249.4%$810.28MN/A0.00N/AHigh Trading VolumeTDOCTeladoc Health2.2751 of 5 stars$11.53-3.8%$12.08+4.8%-42.3%$1.99B$2.59B-2.105,600Analyst ForecastPositive NewsSBCSBC Medical GroupN/A$6.86-5.1%N/AN/A$706.72M$223.34M0.00N/APositive NewsAUNAAuna3.7358 of 5 stars$7.00-2.6%$13.40+91.4%N/A$517.43M$4.34B0.0014,958Short Interest ↓AIRSAirSculpt Technologies0.4736 of 5 stars$6.90+1.0%$5.00-27.5%+33.9%$399.39M$188.78M-48.79346Short Interest ↑LFMDLifeMD2.5042 of 5 stars$6.53-0.9%$12.40+89.9%-20.6%$282.83M$193.06M-10.08230Analyst ForecastPositive NewsSHLTSHL Telemedicine2.1358 of 5 stars$2.82-0.7%$11.00+290.1%-71.4%$41.40M$57.08M0.00583Positive NewsGap DownCCMConcord Medical Services1.3774 of 5 stars$4.67-8.3%N/A-54.4%$20.27M$75.69M0.00970Analyst ForecastNews CoverageTOIOncology Institute2.8138 of 5 stars$0.15-6.2%$2.50+1,545.8%-87.4%$11.48M$378.93M-0.20660Gap UpHigh Trading VolumeHIMSHims & Hers Health3.545 of 5 stars$31.67-1.7%$21.43-32.3%+265.0%$6.92B$1.24B71.771,046Analyst ForecastInsider TradeShort Interest ↑XENEXenon Pharmaceuticals2.6948 of 5 stars$42.03-1.4%$57.45+36.7%+14.1%$3.20B$9.43M0.00251Positive News Related Companies and Tools Related Companies Teladoc Health Competitors SBC Medical Group Competitors Auna Competitors AirSculpt Technologies Competitors LifeMD Competitors SHL Telemedicine Competitors Concord Medical Services Competitors Oncology Institute Competitors Hims & Hers Health Competitors Xenon Pharmaceuticals Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:OAC) was last updated on 12/4/2024 by MarketBeat.com Staff From Our PartnersI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredLock in this share price before 12/5When the team that built Zillow into a $16B real estate leader launches a new company, it’s worth paying atten...Pacaso | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredStrange: Why is Amazon suddenly yielding 39.70%?Something big is happening with Amazon stock… While most investors collect ZERO dividends from Amazon… A...Investors Alley | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredFed Declares War on AmericansFed Declares War on Americans Protect your wealth in the coming months… True Gold Republic | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oaktree Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oaktree Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OAC Stock Alerts